Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacology, selection and complications associated with neuromuscular blocking drugs in ICU patients.

× No keyword cloud information.

49 in total

1. Prolonged reversible quadriparesis in mechanically ventilated patients who received long-term infusions of vecuronium.

Authors: B D Margolis; D Khachikian; Y Friedman; C Garrard
Journal: Chest Date: 1991-09 Impact factor: 9.410

2. Economic impact of prolonged motor weakness complicating neuromuscular blockade in the intensive care unit.

Authors: M I Rudis; B J Guslits; E L Peterson; S J Hathaway; E Angus; S Beis; B J Zarowitz
Journal: Crit Care Med Date: 1996-10 Impact factor: 7.598

3. Prolonged paralysis after treatment with neuromuscular junction blocking agents.

Authors: J L Gooch; M R Suchyta; J M Balbierz; J H Petajan; T P Clemmer
Journal: Crit Care Med Date: 1991-09 Impact factor: 7.598

4. Doxacurium infusion in critically ill patients with atracurium tachyphylaxis.

Authors: D B Coursin; D A Meyer; R C Prielipp
Journal: Am J Health Syst Pharm Date: 1995-03-15 Impact factor: 2.637

5. Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit.

Authors: A H Boyd; N B Eastwood; C J Parker; J M Hunter
Journal: Br J Anaesth Date: 1996-03 Impact factor: 9.166

6. Double-blind, randomized, multicenter study of doxacurium vs. pancuronium in intensive care unit patients who require neuromuscular-blocking agents.

Authors: M J Murray; D B Coursin; P E Scuderi; G Kamath; D S Prough; D M Howard; M A Abou-Donia
Journal: Crit Care Med Date: 1995-03 Impact factor: 7.598

7. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients.

Authors: R C Prielipp; D B Coursin; P E Scuderi; D L Bowton; S R Ford; V J Cardenas; J Vender; D Howard; E J Casale; M J Murray
Journal: Anesth Analg Date: 1995-07 Impact factor: 5.108

8. The pharmacodynamics and pharmacokinetics of the metabolite 3-desacetylvecuronium (ORG 7268) and its parent compound, vecuronium, in human volunteers.

Authors: J E Caldwell; J Szenohradszky; V Segredo; P M Wright; C McLoughlin; M L Sharma; L D Gruenke; D M Fisher; R D Miller
Journal: J Pharmacol Exp Ther Date: 1994-09 Impact factor: 4.030

Review 9. The use of neuromuscular blocking drugs in intensive care practice.

Authors: J M Elliot; J F Bion
Journal: Acta Anaesthesiol Scand Suppl Date: 1995

10. Practice parameters for sustained neuromuscular blockade in the adult critically ill patient: an executive summary. Society of Critical Care Medicine.

Authors: B A Shapiro; J Warren; A B Egol; D M Greenbaum; J Jacobi; S A Nasraway; R M Schein; A Spevetz; J R Stone
Journal: Crit Care Med Date: 1995-09 Impact factor: 7.598